FIELD: chemistry; pharmaceutics.
SUBSTANCE: disclosed is a pharmaceutical composition for treating or preventing reproductive disorders in men, containing in an effective amount: peptides consisting of fragment of 10-20 consecutive amino acid residues of histone H2B protein of type 1 sequence SEQ ID NO: 1, wherein said fragment includes the amino acid sequence SEQ ID NO: 2; peptides consisting of fragment of 10-20 consecutive amino acid residues of the Chaperone protein of the endoplasmic reticulum of the sequence SEQ ID NO: 3, wherein said fragment includes the amino acid sequence SEQ ID NO: 4; peptides consisting of fragment of 10-20 consecutive amino acid residues of the protein Elongation factor 1-alpha-1 of the sequence SEQ ID NO: 5, wherein said fragment includes the amino acid sequence SEQ ID NO: 6; and a carrier. Also disclosed is the use of said pharmaceutical composition in an effective amount for treating or preventing reproductive disorders in men.
EFFECT: group of inventions provides implementation of the purpose.
4 cl, 6 dwg, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING ERECTILE DYSFUNCTION IN MEN AND USE THEREOF | 2024 |
|
RU2837354C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING ENDOTHELIAL DYSFUNCTION AND/OR ATHEROSCLEROTIC VASCULAR DISEASE AND USE THEREOF | 2023 |
|
RU2829346C1 |
ANTIGENIC PEPTIDES FOR PREVENTION AND TREATMENT OF B-CELL HEMOBLASTOSIS | 2020 |
|
RU2833806C1 |
BISPECIFIC ANTIBODIES AND THEIR APPLICATIONS | 2022 |
|
RU2821577C2 |
CHIMERIC CYTOKINE RECEPTORS CARRYING PD-1 ECTODOMAIN | 2020 |
|
RU2828214C2 |
PROPERDIN ANTIBODIES AND PRODUCTION THEREOF | 2021 |
|
RU2830308C1 |
POLYPEPTIDE COMPRISING ANTIGEN-BINDING DOMAIN AND TRANSPORTING SEGMENT | 2018 |
|
RU2841528C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING REPRODUCTIVE AND ERECTILE DYSFUNCTIONS IN MEN AND USE THEREOF | 2023 |
|
RU2825382C1 |
ISOLATED MODIFIED CAPSID PROTEIN VPI OF ADENO-ASSOCIATED VIRUS SEROTYPE 5 (AAV5), CAPSID AND VECTOR BASED THEREON | 2021 |
|
RU2820088C1 |
MONOCLONAL ANTIBODIES SPECIFIC TO PROTEIN RUSTICYANIN, AND USE OF ANTIBODIES FOR DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS | 2024 |
|
RU2823344C1 |
Authors
Dates
2025-03-27—Published
2024-07-13—Filed